BioSyent Inc. (CVE:RX) Director Rene Goehrum Sells 1,522 Shares
BioSyent Inc. (CVE:RX – Get Free Report) Director Rene Goehrum sold 1,522 shares of the business’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of C$9.38, for a total transaction of C$14,276.36. BioSyent Price Performance CVE:RX opened at C$9.21 on Thursday. The firm has a market capitalization […]
More Stories
What Trump’s National Security Strategy Means for Canada
By Noe Chartier Canada receives but a passing mention in the recently released U.S. National Security Strategy, but that doesn’t...
Italy Arrests 9 for Allegedly Using Charities to Fund Hamas Terrorists
By Tom Ozimek Italian authorities have arrested nine people on suspicion of financing Hamas through a network of charities operating...
Winter Weather Cancels Over 1,000 Flights Across US
By Jacki Thrapp Travelers may need to pack their patience on Dec. 27 as winter weather in the Northeast prompted...
Trump Says 2026 Midterms Will Be Referendum on Prices, Economic Success
By Tom Ozimek President Donald Trump said he expects the 2026 midterm elections to hinge on prices and perceptions of...
Canada Offers Ukraine Additional $2.5 Billion in Aid
By Jacki Thrapp Canadian Prime Minister Mark Carney announced on Dec. 27 that Canada will provide an additional $2.5 billion...
Retail in 2025: A Roller Coaster Year—What’s Next in 2026
By Panos Mourdoukoutas The retail industry experienced significant volatility in 2025, as elevated inflation, a weakening labor market, rising household...